Single center experience of five diffuse panbronchiolitis patients clinically presenting as severe asthma

J Korean Med Sci. 2015 Jun;30(6):823-8. doi: 10.3346/jkms.2015.30.6.823. Epub 2015 May 13.

Abstract

Diffuse panbronchiolitis (DPB) is a bronchiolitis affecting the whole lung fields which can be treated by macrolide. Especially East Asian patients are more susceptible to diffuse panbronchiolitis. As asthma and DPB both can cause airway obstruction, differential diagnosis is important for the 2 diseases. Here we report 5 patients with DPB clinically presenting as severe asthma in Korea, who were well treated by macrolide. Among the 5 patients, 2 could stop their asthma inhalers and the other 3 could reduce asthma medications after diagnosis and treatment of DPB. In conclusion, considering DPB as differential diagnosis for asthmatics in Asian ethnic groups is important.

Keywords: Asthma; Clarithromycin; Diffuse Panbronchiolitis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Anti-Asthmatic Agents / therapeutic use*
  • Asthma / diagnosis*
  • Asthma / drug therapy*
  • Bronchiolitis / diagnosis*
  • Bronchiolitis / drug therapy*
  • Diagnosis, Differential
  • Female
  • Haemophilus Infections / diagnosis*
  • Haemophilus Infections / drug therapy*
  • Humans
  • Macrolides / administration & dosage*
  • Male
  • Middle Aged
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Anti-Asthmatic Agents
  • Macrolides

Supplementary concepts

  • Diffuse panbronchiolitis